PATENT CLAIM ANALYSIS

Application Number: 16087223
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "016500"]

Abstract:
Disclosed are CD31 shed  agonists for use in the prevention and/or treatment of reperfusion injury. These CD31 shed  agonists are peptides or peptidomimetics thereof that are able to restore CD31 signaling in cells bearing a truncated form of CD31 called CD31 shed . The CD31 shed  agonists particularly protect from organ damages caused by reperfusion used to treat ischemia.

Claim (Index 23):
The method according to  claim 15 , wherein said reperfusion is used for treating ischemia and wherein said ischemia is selected in the group consisting of myocardial infarction, ischemic colitis, mesenteric ischemia, stroke, ischemia of the lower limbs, visceral ischemia resulting from acute hypovolemia, ischemia resulting from inflammatory conditions, ischemia inherent to an extracorporeal circulation blood excluding part of the arterial branches, ischemia inherent to a visceral and/or aortic surgery, cold ischemia, ischemia inherent to a warm reperfusion of a graft directed to organ transplantation, and their combinations.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.4186
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14809603', '13001513', '12645991', '11901939', '13782881']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8220914443333517
- 35 USC 102 Novelty (BERT): 0.5271502027640903
- Combined Prediction Score: 0.7925973201764256
- Mean Citation Score: 325.796382
- Max Citation Score: 339.41687
- Similarity Product: 193.60726683634044

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test